
Founded
31 Dec 2019
Address
Gilgamesh Pharmaceuticals Inc
113 University Place
Suite 1019
New York, NY 10003
United States
Gilgamesh Pharmaceuticals Inc
201 Dam Trail
#1349
Linville, NC 28646
United States
Phone
Business classification
VCID: 7302621
Profile
Corporate information
Official name
Gilgamesh Pharmaceuticals Inc
Registration country
Official identities
US CIK 0001817048
Investment activity status
Active investor
Company type
Novel psychedelic-Inspired therapeutics for treating mental illness.Overview
Gilgamesh is a discovery and early development biotech company developing small molecules complemented by biomarkers to treat mental illness. The company leverages deep expertise in the medicinal chemistry and neuroscience of psychedelic compounds to develop innovative medicines.
Team
Current employees
![]() |
Andrew Kruegel | founder | |
![]() |
Dalibor Sames | founder | |
![]() |
Jonathan Sporn | founder |
Funding
Funding rounds
(31 Dec 2019)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Y Combinator | American technology startup accelerator. | United States | Initial investment. Led the round. |
Cap Table
Current and past shareholders
Investor | Round | |
---|---|---|
![]() |
Y Combinator American technology startup accelerator. |
Seed |